10 Among hematopoietic neoplasms, the B-B4 MoAb
O specifically identifies multiple myeloma cells. 10 Thus, B-B4
VER THE LAST 25 YEARS, it has become evident that the nodular lymphocyte predominance (LP) subcan be considered a bona fide specific marker for terminally type of Hodgkin's disease (HD) may represent a germinal differentiated B cells, although its expression has been decenter-related B-cell clinicopathological entity.
1 It can be distected, at a low cellular density, in some human leukemic tinguished from classical HD by clinicopathological, phenocell lines of pre-B phenotype. 10 The cDNA of the B-B4 typic, and molecular features. 1, 2 antigen encodes syndecan-1, 10 a member of a family of transIn contrast to nodular LP HD, the lineage of Reed-Sternmembrane heparan sulfate proteoglycans thought to be inberg (RS) cells in cases of classical HD, including nodular volved in binding cells of the B lineage to the interstitial sclerosis (NS) and mixed cellularity (MC) subtypes, continmatrix. 11 Notably, among the various stages of B-cell differues to be debated, as most studies analyzing conventional entiation, high levels of syndecan-1 mRNA have been de-B-and T-cell markers on these HD subtypes have shown tected only at pre-B cell and plasma cell stages, 12,13 fully heterogeneous phenotypes (reviewed in Harris et al 2 and reflecting the reactivity patterns of the B-B4 MoAb. 
somatic mutations of Ig variable region heavy chain (V H )
Submitted November 18, 1996; accepted January 6, 1997. genes. Notably, somatic mutations of Ig V H genes are detect- within the same histologic subtype of HD. 7-9 Taken together, by incubating anti-B-B4 MoAb, with the addition of 3% normal * U, undetermined.
human serum, for 1 hour at room temperature. † Weak expression.
Deparaffinized and cryostat sections were used for further immu- ‡ Strong expression in most RS cells.
nophenotyping and lineage assignment of HD cases. Source and § Weak to moderate expression.
specificities of antibodies used in this study have been reported in detail previously.
15,16
Immunohistochemistry was performed with the alkaline phosphatase antialkaline phosphatase (APAAP) method as described.
17 Naphthol AS-MX phosphate along with Fast Red TR salt (with the addiat assessing its potential use to further define the differentia- The diagnosis of B-cell NHL/leukemia was based on correlative all 56 HD cases included in the study. The MoAb was also applied showed a strong cytoplasmic and membrane staining of KM-H2, and HDLM-2 were described in detail previously. 18 HDderived cell lines, KG-1A (acute myeloid leukemia), U266 and LPplasma cells, being overall unreactive with other cell popula-1 (multiple myeloma) cell lines were obtained through the German tions (not shown). Blood vessels were usually negative. Table 2 . 
MATERIALS AND METHODS
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Expression of B-B4 and syndecan-1 in human HD-derived
demonstrate that cultured RS cells of B and undetermined phenotype express syndecan-1-specific mRNA and produce and myeloma/leukemia cell lines. On cytospin preparations, HD cell lines were consistently stained by anti-B-B4 a form of syndecan-1 recognized by the B-B4 MoAb that is predominantly associated with glycosaminoglycans and is MoAb irrespective of their antigenic profiles, which encompassed B (KM-H2) and undetermined (non-T, non-B) (L428) present at the cell surface. phenotypes. Cultured RS cells were characterized by a strong granular or diffuse cytoplasmic staining with anti-B-B4 MoAb (Fig 2A) ; on a number of cells, this staining was associated with labelling on the cell membranes, leading to an overall picture closely resembling that observed by us on RS cells in HD tissues.
To determine whether the MoAb B-B4 was able to identify syndecan-1 localized at the surface of cultured RS cells, we stained HD cell lines and compared the results with other human tumor cell lines. Analysis of flow cytometry profiles (Fig 2B) indicated that L428 and KM-H2 cells were stained by the MoAb B-B4 at a high and intermediate fluorescence intensity, respectively. Myeloma cell lines U266 and LP-1 were both stained at a very high fluorescence intensity, while KG-1A leukemic cells did not react with the B-B4 MoAb (Fig 2B) .
Expression of syndecan-1 mRNA was also studied by RT-PCR. As shown in Fig 3A, an 812-bp amplified cDNA product specific for syndecan-1 was detectable in both HDderived cell lines (L428, KM-H2) and in myeloma cell lines (U266, LP-1) expressing surface B-B4, but not in myeloid leukemic cells (KG-1A), which were unreactive with the B-B4 MoAb and in a HD-derived cell line of T-cell phenotype (HDLM-2). The specificity of the PCR amplified products was also assessed by Southern blot hybridization with a syndecan-1 oligoprobe (Fig 3A) .
To further characterize the molecular structures recognized by the B-B4 MoAb on cultured RS cells, we have analyzed cell lysates subjected to SDS-PAGE and Western blotting analysis. On cell lysates from human myeloma cells U266 and the HD cell line L428 (Fig 3B) , the MoAb B-B4 showed a pattern consisting of a predominant broad smear starting at about 200 kD plus other less represented components of about 77 to 75 kD. This pattern is consistent with the detection of syndecan-1 molecules predominantly bearing different amounts of glycosaminoglycanes, with the lower molecular weight components being related to the core protein.
10,11,24 A similar profile was observed in KM-H2 cells (not shown). In contrast, no syndecan-1-related molecular components were immunodected by MoAb B-B4 on cell lysates from negative control cells KG-1A (Fig 3B) or when the blot was incubated with an irrelevant isotype-matched control mouse MoAb (not shown). Taken together, these data For
DISCUSSION
Although the cellular origin of RS cells of classical HD has not been totally clarified, recent immunophenotypic and molecular studies 4-9 have suggested that RS cells of a subset of classical HD cases might represent a B-cell-derived monoclonal population. Presumably, the precise stage of Bcell differentiation of RS cells varies among different cases, even within the same histologic subtype of classical HD.
To further define the differentiation stage of RS cells and their variants, we have investigated the expression of B-B4, a specific marker for terminally differentiated B cells, 10 in a large series of HD samples representative of different histologic subtypes and immunophenotypes. For comparison, B-B4 reactivity was also assessed in a panel of B-cell malignancies at different stages of differentiation and in non-neoplastic lymph nodes. We have shown that RS cells and their morphologic variants of classical HD expressed B-B4 in 48 of 48 cases, irrespective of the HD histologic subtype (NS and MC) and of their antigenic phenotype (B and undetermined). Conversely, RS cells of nodular LP HD were consistently unreactive with the B-B4 MoAb. Among classical HD cases we have observed, however, a certain heterogeneity in the number of reactive tumor cells and the intensity of staining, with the percentage of RS cells and variants expressing B-B4 ranging from 10% to more than 75%, among different cases. The staining of RS cells with the anti-B-B4 MoAb was of variable intensity on the cytoplasms being always associated with cell membranes reactivity. Despite this heterogeneity, RS cells from NS HD appeared to display a higher reactivity and a stronger staining intensity than tumor cells of the MC subtype.
Among B-cell NHL/leukemia and multiple myeloma/plasmaytoma samples, the reactivity of B-B4 MoAb was restricted to cases of lymphoplasmacytoid lymphoma, immunoblastic plasmacytoid lymphoma, and multiple myeloma/ plasmaytoma, confirming the specificity of B-B4 for the terminally differentiated B cell. 10 In keeping with these findings, B-B4 MoAb was highly reactive with normal plasma cells of all non-neoplastic lymph node samples and with plasma cells in the context of HD biopsies. B-B4 MoAb stained HD-derived cell lines L428 and KM-H2 and the myeloma cell lines U266 and LP-1, as assessed by immunocytochemistry and flow cytometry. Furthermore, mRNA for face. The frequent and selective occurrence of B-B4 expression in classical HD provides further evidence favoring that the disease may frequently represent a neoplasm of postgerminal center B-cell origin, and thus supporting previous molecular findings. [6] [7] [8] [9] In addition, we provide the first phenotypic evi- and tumor cell types before they can be released from tissues, 
